- $22.17bn
- $25.18bn
- $5.14bn
- 89
- 23
- 76
- 67
Annual cashflow statement for Steris, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 408 | 397 | 243 | 106 | 380 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 25.8 | 50.3 | 145 | 534 | 305 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -49.7 | 19 | -149 | -250 | -146 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | 591 | 690 | 685 | 757 | 973 |
| Capital Expenditures | -215 | -239 | -288 | -362 | -360 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -105 | -915 | -379 | -21.4 | -527 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -320 | -1,154 | -667 | -383 | -887 |
| Financing Cash Flow Items | 2.9 | -17.2 | -47.5 | -2.27 | -4.81 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -163 | 346 | 116 | -499 | -85.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 98.9 | -99 | 128 | -140 | -1.34 |